REGN

Regeneron Pharmaceuticals, Inc. $781.49 1M -2.1% 3M +27.8% YTD +0.7% as of 2026-09-11
+Watchlist

↑↓ next ticker · ⌘+↑↓ or scroll to zoom · ←→ pan · 0 reset

▲ buy   ▼ sell  ·  size ≈ trade size  · earnings ● beat ● miss  ·  ring ◯ before open ◯ after close  · ─ moving averages · click the buttons above to hide them

Model view — historical tendencies for the days ahead, not a forecast
Next 1 day
+0.3%
Next 1 week
+0.5%
Next 1 month
-0.6%
Seasonality
No real seasonal tilt
Next 30 days (to Oct 14): +0.2% median, 53% of the last 34 years finished up.
20-year seasonality chart →
Mean reversion
Deeply oversold — RSI(2) at 3
RSI(2) under 15 is oversold (this name has historically bounced); over 85 is overbought. Its dip-buy edge in history is +0.31%/day.
Mean-reversion stats →
1-month breakdown — Market · β 0.49 -0.1% · Seasonal tilt -0.5%
$84.1B market cap (#138 US) $508M/day volume 34% volatility +41% 1-year -36% from ATH
52-week range · 76% of the way up · -9% from the high
$541.00$859.34

Congressional trades in REGN Full tracker →

21 members · 37 buys / 43 sells · $278K–$1.6M disclosed · latest filing Jul 21, 2026.

BUY AA Alan Armstrong · traded Mar 27, 2026 $1K–$15K
SELL GC Gilbert Cisneros · traded May 15, 2026 $1K–$15K
BUY JL Julia Letlow · traded Feb 12, 2026 $1K–$15K
BUY GC Gilbert Cisneros · traded Nov 18, 2025 $1K–$15K
BUY RB Rob Bresnahan · traded May 15, 2025 $1K–$15K
SELL BD Byron Donalds · traded Apr 10, 2025 $1K–$15K
SELL JJ Julie Johnson · traded Apr 1, 2025 $1K–$15K
SELL RB Rob Bresnahan · traded Apr 8, 2025 $1K–$15K

Earnings Full history →

Next report 2026-10-28 (Wednesday, before open, in 44 days) · EPS est. 15.94.

1-day std dev
4.8%
Finished up
60%
Biggest pop
+12.3%
Biggest drop
-9.2%

Standard deviation of the close-to-close move over the last 60 reports. History, not a forecast.

Data from the U.S. House Clerk and FINRA, plus end-of-day prices. Not investment advice.